Stockscreener 앱 받기
10.21
4.50%
0.44
시간 외 거래:
10.21
전일 마감가:
$9.77
열려 있는:
$10.03
하루 거래량:
1.75M
Relative Volume:
0.70
시가총액:
$1.20B
수익:
$2.35B
순이익/손실:
$-74.42M
주가수익비율:
-10.86
EPS:
-0.94
순현금흐름:
$150.93M
1주 성능:
-10.75%
1개월 성능:
-2.76%
6개월 성능:
+0.29%
1년 성능:
-50.96%
1일 변동 폭
$9.99
$10.31
1주일 범위
$9.2201
$11.81
52주 변동 폭
$7.06
$33.48
Evolent Health Inc Stock (EVH) Company Profile
명칭
Evolent Health Inc
전화
571-389-6000
주소
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
EVH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
10.21 | 1.15B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
286.01 | 46.61B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
64.86 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
96.91 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
61.00 | 11.13B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.96 | 6.33B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 개시 | Needham | Buy |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-11-08 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | 업그레이드 | Truist | Hold → Buy |
| 2024-04-22 | 개시 | Citigroup | Buy |
| 2024-03-01 | 개시 | Oppenheimer | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-10-16 | 개시 | UBS | Buy |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2022-11-01 | 개시 | Truist | Hold |
| 2022-07-29 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-11-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-04-29 | 재개 | JP Morgan | Neutral |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-07-06 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-06-02 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | 재개 | Leerink Partners | Outperform |
| 2018-06-04 | 개시 | Piper Jaffray | Overweight |
| 2018-04-24 | 재개 | JP Morgan | Neutral |
| 2017-09-20 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | 개시 | Robert W. Baird | Outperform |
| 2017-03-14 | 개시 | Oppenheimer | Outperform |
| 2017-01-13 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | 재개 | JP Morgan | Overweight |
| 2016-08-05 | 재확인 | FBR Capital | Outperform |
| 2016-07-26 | 개시 | Jefferies | Buy |
| 2016-07-13 | 재확인 | FBR Capital | Outperform |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2016-01-06 | 개시 | Canaccord Genuity | Buy |
| 2015-06-30 | 개시 | Goldman | Buy |
| 2015-06-30 | 개시 | JP Morgan | Overweight |
| 2015-06-30 | 개시 | Leerink Partners | Outperform |
| 2015-06-30 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Evolent Health Inc 주식(EVH)의 최신 뉴스
Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know - TradingView
What analysts say about Evolent Health Inc. stockFree Stock Market Beginners Guide - Autocar Professional
Is Evolent Health Inc. a good long term investmentHigh-yield investments - jammulinksnews.com
What drives Evolent Health Inc. stock priceFree Smart Trading Workshop - Autocar Professional
Evolent Health Inc. Stock Analysis and ForecastFree Investment Timing Strategies - jammulinksnews.com
Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance
The Analyst Verdict: Evolent Health In The Eyes Of 5 Experts - Nasdaq
Truist Securities Raises Price Target for Evolent Health (EVH) | - GuruFocus
Evolent Health: Truist Securities Maintains Buy, Raises PT to $16 from $14. - AInvest
Evolent Health Insiders Added US$1.35m Of Stock To Their Holdings - 富途牛牛
Evolent Health Announces Q2 Earnings Date and Major Growth Conference Appearance - Stock Titan
Evolent Health, Inc. (NYSE:EVH) Stock Catapults 35% Though Its Price And Business Still Lag The Industry - simplywall.st
Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - Yahoo Finance
EVH Press Release: Evolent To Release Second Quarter 2025 Financi... - 富途牛牛
Evolent Health taps David Lim as chief clinical officer - MSN
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know - TradingView
BPAS - FinancialContent
Evolent adds Dr. David Lim as chief clinical officer, John Way as CFO By Investing.com - Investing.com South Africa
Evolent Health Appoints Dr. David Lim as Chief Clinical Officer; John Way as CFO, Performance Suite - citybiz
Evolent adds Dr. David Lim as chief clinical officer, John Way as CFO - Investing.com
Former OptumHealth CFO Joins Evolent as Healthcare Giant Expands Specialty Care Leadership - Stock Titan
Evolent Health stock rating reaffirmed at Buy by Truist on managed care trends - Investing.com Canada
The Top 5 Analyst Questions From Evolent Health’s Q1 Earnings Call - Yahoo Finance
SUN extends revolver to 2030, upsizes to $2.46B for Parkland deal | EVH SEC FilingForm 4 - Stock Titan
JMP Maintains Price Target and Market Outperform Rating on Evolent Health (EVH) - Insider Monkey
Evolent Health, Inc.(NYSE: EVH) added to Russell Small Cap Comp Value Index - MarketScreener
3 Reasons to Avoid EVH and 1 Stock to Buy Instead - Yahoo Finance
EVH Stock Up 30% after 5-Day Win Streak - Trefis
Evolent Health (EVH) Announces Positive Developments Amid Market Concerns | EVH Stock News - GuruFocus
Evolent Health (EVH) Rating Reaffirmed by JMP Securities | EVH S - GuruFocus
Evolent reiterates Q2 and full year guidance for Adjusted EBITDA - Finansavisen
Evolent Health Amends Credit Agreement for Flexibility - TipRanks
EVH Q1 Earnings Call: Oncology Navigation Launch and AI Automation Drive Strategic Focus - Yahoo Finance
Evolent Health, Inc. Appoints Shawn Guertin to the Board of Directors and Reconstitutes Compositions of Committees, Effective June 5, 2025 - marketscreener.com
3 Stocks Under $10 in the Doghouse - Yahoo Finance
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Evolent Health, Inc. To Contact The Firm - ACCESS Newswire
Evolent Health at William Blair Conference: Strategic Growth Amid Challenges - Investing.com Australia
Evolent Health Reaffirms 2025 Revenue and EBITDA Guidance - TipRanks
Evolent HealthReaffirms 2025 Revenue Guidance Of $2.06 Bln To $2.11 BlnSEC Filing - marketscreener.com
Evolent Health Inc (EVH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.69%
자본화:
|
볼륨(24시간):